Clinical Nurse Specialist · Murrieta, CA
NPI
1871910950
Since 2014
Specialty
Clinical Nurse Specialist
Code 364S00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
25405 Hancock Ave Ste 200
Murrieta, CA, 92562
Phone (951) 200-2090
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
1,551 services
Medicare patients, 2024
255
Average age 71
Drug cost, 2024
$746K
2,447 prescriptions
Company payments, 2025
$3,923
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carmen Huerta was code 17003 (destruction skin lesion), 603 times for 97 patients. In total Carmen Huerta billed 1,551 services in 41 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 603 | 97 | $4.40 | $2,652 |
| 17000 Destruction Skin Lesion | Office | 155 | 117 | $25.52 | $3,956 |
| 17110 Destruction Skin Lesion | Office | 152 | 126 | $71.72 | $11K |
| 99213 Office E&M - Established | Office | 137 | 98 | $51.89 | $7,110 |
| 99203 Office E&M - New | Office | 94 | 94 | $57.59 | $5,413 |
| 11102 Skin Biopsy | Office | 75 | 65 | $41.59 | $3,119 |
| 99214 Office E&M - Established | Office | 60 | 49 | $81.39 | $4,883 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 52 | 19 | $0.69 | $36.02 |
| 99204 Office E&M - New | Office | 33 | 33 | $101.26 | $3,342 |
| 11900 Skin | Office | 21 | 16 | $29.33 | $616 |
| 17004 Destruction Skin Lesion | Office | 19 | 14 | $118.14 | $2,245 |
| 11200 Removal or Shaving of Skin Growth | Office | 18 | 18 | $32.93 | $593 |
| 17111 Destruction Skin Lesion | Office | 18 | 15 | $76.01 | $1,368 |
| 11103 Skin Biopsy | Office | 16 | 13 | $27.95 | $447 |
| 99212 Office E&M - Established | Office | 15 | 15 | $31.74 | $476 |
By year: 2022 $35K for 892 services; 2023 $44K for 1,146 services; 2024 $53K for 1,551 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carmen Huerta prescribed most often to Medicare patients was Ketoconazole, with 532 prescriptions and refills. In total Carmen Huerta wrote 2,447 Medicare prescriptions that cost $746K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 532 | 547 | 258 | $6,824 |
| Clobetasol Propionate Generic | 306 | 311 | 166 | $8,520 |
| Triamcinolone Acetonide Generic | 283 | 320 | 210 | $3,161 |
| Clindamycin Phosphate Generic | 137 | 145 | 59 | $4,046 |
| Mupirocin Generic | 125 | 126 | 94 | $932 |
| Doxycycline Hyclate Generic | 119 | 135 | 79 | $1,323 |
| Hydrocortisone Generic | 107 | 109 | 80 | $505 |
| Fluorouracil Generic | 101 | 103 | 91 | $5,600 |
| Tacrolimus Generic | 76 | 80 | 48 | $6,742 |
| Ciclopirox Generic | 70 | 70 | 38 | $1,822 |
| Metronidazole Generic | 56 | 63 | 32 | $2,611 |
| Dupixent Pen Dupilumab | 52 | 52 | 11 | $189K |
| Tretinoin Generic | 52 | 58 | 30 | $3,356 |
| Fluocinonide Generic | 40 | 41 | 18 | $1,174 |
| Adbry Tralokinumab-Ldrm | 40 | 40 | Under 11 | $149K |
Brand drugs: 220 claims; generic drugs: 2,227 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carmen Huerta $3,923 ($3,923 in general payments such as food, travel and fees) from 18 companies. The largest payer was LEO Pharma Inc. with $930.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 47 | $930 |
| Galderma Laboratories, L.P. GALD.SW | 24 | $588 |
| Incyte Corporation INCY | 31 | $398 |
| Amgen Inc. AMGN | 19 | $336 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $335 |
| Abbvie Inc. ABBV | 16 | $229 |
| Arcutis Biotherapeutics, Inc. ARQT | 9 | $207 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $198 |
| Genzyme Corporation SNY | 7 | $179 |
| UCB, Inc. UCB.BR | 7 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.